- NEWS FEATURE
How ecstasy and psilocybin are shaking up psychiatry
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Nature 589, 506-509 (2021)
doi: https://doi.org/10.1038/d41586-021-00187-9
References
Davis, A. K. et al. JAMA Psychiatry http://doi.org/10.1001/jamapsychiatry.2020.3285 (2020).
Agin-Liebes, G. I. et al. J. Psychopharmacol. 34, 155–166 (2020).
Carhart-Harris, R. L. et al. Psychopharmacology 235, 399–408 (2018).
Vollenweider, F. X. & Preller, K. H. Nature Rev. Neurosci. 21, 611–624 (2020).
Vollenweider, F. X. et al. Neuropsychopharmacology 16, 357–372 (1997).
Zhang, G. et al. Neuropharmacology 64, 403–413 (2013).
Hutten, N. R. P. W. et al. ACS Pharmacol. Transl. Sci. https://doi.org/10.1021/acsptsci.0c00099 (2020).
Lebedev, A. V. et al. Hum. Brain Mapp. 37, 3203–3213 (2016).